ALX Oncology Holdings (ALXO)
(Delayed Data from NSDQ)
$14.66 USD
-0.36 (-2.40%)
Updated May 16, 2024 04:00 PM ET
After-Market: $14.68 +0.02 (0.14%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.75 |
EPS Last Quarter | -0.71 |
Last EPS Surprise | 18.39% |
ABR | 1.29 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.89 |
Next Year | -2.73 |
EPS (TTM) | -3.72 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.75 | -0.69 | -2.89 | -2.73 |
# of Estimates | 5 | 5 | 6 | 3 |
Most Recent Consensus | -0.70 | -0.64 | -2.73 | -2.13 |
High Estimate | -0.69 | -0.59 | -2.56 | -2.13 |
Low Estimate | -0.84 | -0.82 | -3.16 | -3.34 |
Year ago EPS | -0.84 | -1.24 | -3.74 | -2.89 |
Year over Year Growth Est. | 10.71% | 44.35% | 22.73% | 5.65% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 4 | 2 | 5 | 3 |
Up Last 30 Days | 4 | 2 | 5 | 3 |
Up Last 60 Days | 4 | 2 | 5 | 3 |
Down Last 7 Days | 0 | 1 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 0 | 0 |
Down Last 60 Days | 0 | 1 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.75 | -0.69 | -2.89 | -2.73 |
7 Days Ago | -0.87 | -0.79 | -3.33 | -2.85 |
30 Days Ago | -0.87 | -0.79 | -3.33 | -2.85 |
60 Days Ago | -0.87 | -0.79 | -3.33 | -2.85 |
90 Days Ago | -0.86 | -0.80 | -3.41 | -3.09 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.75 | -0.70 | -2.89 | -2.73 |
Zacks Consensus Estimate | -0.75 | -0.69 | -2.89 | -2.73 |
Earnings ESP | 0.00% | -1.23% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.71 | -0.93 | -1.24 | -0.84 | NA |
Estimate | -0.87 | -0.84 | -0.86 | -0.85 | NA |
Difference | 0.16 | -0.09 | -0.38 | 0.01 | -0.08 |
Surprise | 18.39% | -10.71% | -44.19% | 1.18% | -8.83% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more